Astria Therapeutics (ATXS) Institutional Ownership → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free ATXS Stock Alerts $9.05 +0.03 (+0.33%) (As of 05/28/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Astria Therapeutics (NASDAQ:ATXS)CurrentInstitutional OwnershipPercentage98.98%Number ofInstitutional Buyers(last 12 months)21TotalInstitutional Inflows(last 12 months)$126.67MNumber ofInstitutional Sellers(last 12 months)9TotalInstitutional Outflows(last 12 months)$24.14M Get ATXS Insider Trade Alerts Want to know when executives and insiders are buying or selling Astria Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ATXS Institutional Buying and Selling by Quarter Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… Astria Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/20/2024 Virtu Financial LLC30,313$427K0.0%N/A0.055% 5/17/2024 RA Capital Management L.P.4,413,150$62.12M0.8%N/A8.037% 5/17/2024 Artal Group S.A.884,214$12.45M0.3%N/A1.610% 5/17/2024 Tidal Investments LLC118,200$1.66M0.0%N/A0.215% 5/15/2024 Price T Rowe Associates Inc. MD14,203$200K0.0%N/A0.026% 5/15/2024 Affinity Asset Advisors LLC845,606$11.90M1.5%-42.3%1.540% Get the Latest News and Ratings for ATXS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Astria Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/14/2024 StemPoint Capital LP230,273$3.24M0.9%-73.1%0.419% 5/14/2024 American International Group Inc.24,565$346K0.0%+49.4%0.045% 5/13/2024 Ameritas Investment Partners Inc.4,971$70K0.0%+135.6%0.009% 5/10/2024 Vanguard Group Inc.2,535,891$35.69M0.0%+23.4%4.618% 5/7/2024 Oppenheimer & Co. Inc.12,944$182K0.0%-10.4%0.024% 4/22/2024 Vivo Capital LLC2,329,027$32.78M2.6%-6.2%4.242% 2/26/2024 Perceptive Advisors LLC4,004,070$30.75M0.7%+82.9%9.032% 2/14/2024 ADAR1 Capital Management LLC191,251$1.47M0.5%N/A0.431% 2/13/2024 Armistice Capital LLC1,578,000$12.12M0.2%N/A3.560% 2/13/2024 Affinity Asset Advisors LLC1,466,465$11.26M2.1%+46.6%3.308% 2/9/2024 Trexquant Investment LP53,204$409K0.0%N/A0.120% 2/8/2024 Panagora Asset Management Inc.15,462$119K0.0%N/A0.035% 2/7/2024 Vivo Capital LLC2,482,727$19.07M1.6%+47.7%5.601% 2/6/2024 AJOVista LLC6,636$51K0.1%N/A0.015% 11/15/2023 Affinity Asset Advisors LLC1,000,300$7.46M2.1%+53.7%3.567% 11/13/2023 Connor Clark & Lunn Investment Management Ltd.42,070$314K0.0%-20.1%0.150% 11/13/2023 FMR LLC2,565,052$19.14M0.0%-13.4%9.148% 11/7/2023 Jump Financial LLC14,926$111K0.0%N/A0.053% 10/24/2023 Stratos Wealth Partners LTD.42,188$315K0.0%-32.6%0.150% 9/21/2023 Barclays PLC9,010$75K0.0%-72.7%0.032% 8/21/2023 Affinity Asset Advisors LLC650,875$5.42M1.9%+23.0%2.321% 8/15/2023 Sphera Funds Management LTD.471,018$3.92M0.6%+11.9%1.680% 8/14/2023 Deep Track Capital LP1,697,415$14.14M0.7%-6.6%6.054% 8/14/2023 Driehaus Capital Management LLC1,455,648$12.13M0.2%+1.6%5.191% 8/4/2023 American International Group Inc.12,296$102K0.0%N/A0.044% 8/3/2023 Oppenheimer & Co. Inc.14,527$121K0.0%-9.4%0.052% 7/25/2023 Raymond James & Associates12,308$103K0.0%N/A0.044% 7/18/2023 Stratos Wealth Partners LTD.62,613$522K0.0%N/A0.223% 5/16/2023 Altium Capital Management LP1,347,088$17.92M9.9%-1.2%4.807% 5/15/2023 Affinity Asset Advisors LLC529,369$7.04M2.3%+12.0%1.889% 5/15/2023 Logos Global Management LP1,044,960$13.90M2.0%+20.8%3.729% 5/12/2023 Mirabella Financial Services LLP28,585$380K0.1%N/A0.102% 5/10/2023 Connor Clark & Lunn Investment Management Ltd.37,519$499K0.0%+112.6%0.134% 5/4/2023 Barclays PLC32,997$439K0.0%N/A0.118% Digitizing the $11T commodities sector with one tiny stock (Ad)One tiny company — trading completely undiscovered around 15-cents per share — has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. It’s an opportunity that likely won’t stay at these levels for long2/15/2023 Fairmount Funds Management LLC1,901,397$28.31M4.5%+108.5%11.300% 2/14/2023 683 Capital Management LLC14,718$219K0.0%N/A0.087% 2/14/2023 Driehaus Capital Management LLC1,337,315$19.91M0.3%+103.7%7.946% 2/14/2023 Dorsey Wright & Associates2,270$34K0.0%N/A0.013% 2/13/2023 Vivo Capital LLC1,681,199$25.03M2.9%+68.1%9.989% 2/10/2023 Opaleye Management Inc.261,703$3.90M1.4%+96.0%1.555% 2/10/2023 Connor Clark & Lunn Investment Management Ltd.17,644$263K0.0%N/A0.105% 2/9/2023 Saturn V Capital Management LLC169,493$1.56M1.3%N/A1.007% 2/8/2023 Oppenheimer & Co. Inc.16,016$238K0.0%-10.1%0.095% 11/15/2022 Tri Locum Partners LP631,579$5.71M1.6%N/A3.754% 11/14/2022 Cormorant Asset Management LP1,200,000$10.85M0.8%+300.0%9.219% 11/14/2022 Vivo Capital LLC1,000,000$9.04M1.0%N/A7.682% 11/14/2022 Boothbay Fund Management LLC101,619$919K0.0%+34.1%0.781% 11/14/2022 Altium Capital Management LP445,000$4.02M1.5%N/A3.419% 11/14/2022 Oppenheimer & Co. Inc.17,816$161K0.0%-24.6%0.137% 11/14/2022 Ghost Tree Capital LLC500,000$4.52M1.3%N/A3.841% 11/7/2022 Jump Financial LLC12,000$108K0.0%N/A0.092% 8/12/2022 Ikarian Capital LLC592,123$1.78M0.3%+542.1%4.549% 2/2/2022 Oppenheimer & Co. Inc.21,816$118K0.0%+78.1%0.168% 12/3/2021 Perceptive Advisors LLC1,959,652$17.32M0.2%N/A15.064% 11/16/2021 VR Adviser LLC538,999$4.77M0.6%N/A13.806% 11/16/2021 Commodore Capital LP239,270$2.12M0.6%N/A6.129% 11/15/2021 RA Capital Management L.P.1,262,193$11.16M0.2%N/A32.331% 11/15/2021 GSA Capital Partners LLP24,996$221K0.0%N/A0.640% 11/12/2021 Renaissance Technologies LLC109,353$967K0.0%N/A2.801% 11/12/2021 Oppenheimer & Co. Inc.12,249$108K0.0%N/A0.314% 11/12/2021 Botty Investors LLC28,247$250K0.1%N/A0.724% 11/12/2021 Artal Group S.A.33,333$295K0.0%N/A0.854% 11/9/2021 BlackRock Inc.41,116$363K0.0%N/A1.054% 9/3/2021Parametric Portfolio Associates LLC115,069$243K0.0%-32.8%2.947% 8/18/2021 Ikarian Capital LLC532,298$1.12M0.1%-37.6%2.273% 8/17/2021 Logos Global Management LP3,190,000$6.73M0.6%N/A13.623% 8/17/2021 Millennium Management LLC461,609$974K0.0%N/A1.971% 8/17/2021 Acuta Capital Partners LLC1,173,674$2.48M1.0%N/A5.012% 8/17/2021 Boothbay Fund Management LLC84,000$177K0.0%-11.9%0.359% 8/17/2021 Boxer Capital LLC1,775,000$3.75M0.1%N/A7.580% 8/16/2021 Squarepoint Ops LLC12,388$26K0.0%N/A0.053% 8/16/2021Corient Capital Partners LLC55,334$117K0.0%-46.5%0.236% 8/16/2021 Commodore Capital LP1,617,000$3.41M1.2%N/A6.905% 8/16/2021 Occudo Quantitative Strategies LP35,066$74K0.0%N/A0.150% 8/16/2021 Perceptive Advisors LLC7,687,185$16.22M0.2%+297.6%32.827% 8/16/2021 RA Capital Management L.P.5,947,861$12.55M0.2%N/A25.400% 8/16/2021 Alyeska Investment Group L.P.1,248,317$2.63M0.0%-32.7%5.331% 8/16/2021 State Street Corp56,999$120K0.0%-89.6%0.243% 8/16/2021Tibra Equities Europe Ltd155,300$328K0.1%N/A0.663% 8/16/2021 Goldman Sachs Group Inc.80,717$170K0.0%+130.7%0.345% 8/13/2021 Renaissance Technologies LLC377,460$796K0.0%+110.8%1.612% 8/13/2021 VR Adviser LLC3,234,000$6.82M0.8%N/A13.810% 8/13/2021 Northern Trust Corp84,357$178K0.0%-67.3%0.360% 8/13/2021 Fairmount Funds Management LLC4,092,166$8.63M3.5%+7,597.0%17.475% Digitizing the $11T commodities sector with one tiny stock (Ad)One tiny company — trading completely undiscovered around 15-cents per share — has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. It’s an opportunity that likely won’t stay at these levels for long8/13/2021 Geode Capital Management LLC188,799$398K0.0%-38.3%0.806% 8/13/2021 Vanguard Group Inc.810,693$1.71M0.0%-7.2%3.462% 8/12/2021 Dimensional Fund Advisors LP61,444$130K0.0%+23.4%0.262% 8/12/2021 JPMorgan Chase & Co.21,811$46K0.0%+168.4%0.093% 8/12/2021Ergoteles LLC91,300$193K0.0%N/A0.390% 8/11/2021 Bank of New York Mellon Corp15,295$32K0.0%-75.8%0.065% 6/10/2021 Perceptive Advisors LLC2,476,924$7.16M0.1%N/A10.577% 5/19/2021 Virtu Financial LLC35,128$102K0.0%-57.8%0.150% 5/18/2021 Samsara BioCapital LLC150,000$434K0.1%-50.0%0.641% 5/17/2021 Perceptive Advisors LLC2,476,924$7.16M0.1%N/A10.577% (Data available from 1/1/2016 forward) ATXS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ATXS shares? During the previous two years, 40 institutional investors and hedge funds held shares of Astria Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($62.12M), Vanguard Group Inc. ($35.69M), Vivo Capital LLC ($32.78M), Perceptive Advisors LLC ($30.75M), Fairmount Funds Management LLC ($28.31M), FMR LLC ($19.14M), and Altium Capital Management LP ($17.92M).Learn more on ATXS's institutional investors. What percentage of Astria Therapeutics stock is owned by institutional investors? 98.98% of Astria Therapeutics stock is owned by institutional investors. Learn more on ATXS's institutional investor holdings. Which institutional investors have been buying Astria Therapeutics stock? Of the 36 institutional investors that purchased Astria Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($4.41M), Vivo Capital LLC ($2.48M), Perceptive Advisors LLC ($1.81M), Armistice Capital LLC ($1.58M), Affinity Asset Advisors LLC ($993.98K), Fairmount Funds Management LLC ($989.66K), and Cormorant Asset Management LP ($900K). How much institutional buying is happening at Astria Therapeutics? Institutional investors have bought a total of 18,540,960 shares in the last 24 months. This purchase volume represents approximately $204.14M in transactions. Which Astria Therapeutics major shareholders have been selling company stock? Of the 10 institutional investors that sold Astria Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: StemPoint Capital LP ($626.68K), Affinity Asset Advisors LLC ($620.86K), FMR LLC ($397.24K), Vivo Capital LLC ($153.70K), Deep Track Capital LP ($119.12K), Barclays PLC ($23.99K), and Stratos Wealth Partners LTD. ($20.43K). How much institutional selling is happening at Astria Therapeutics? Institutional investors have sold a total of 1,999,184 shares in the last 24 months. This volume of shares sold represents approximately $24.43M in transactions. Related Companies: Larimar Therapeutics Institutional Ownership Travere Therapeutics Institutional Ownership IGM Biosciences Institutional Ownership Entrada Therapeutics Institutional Ownership Heron Therapeutics Institutional Ownership KalVista Pharmaceuticals Institutional Ownership Olema Pharmaceuticals Institutional Ownership Applied Therapeutics Institutional Ownership Oculis Institutional Ownership Fulcrum Therapeutics Institutional Ownership This page (NASDAQ:ATXS) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsElon’s New Device is About to Shock the WorldInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astria Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.